STAT3 and pulmonary arterial hypertension: In a word, these results revealed that compound 6 could reduce the downstream protein levels of p-STAT3 and c-Myc by interfering with the interaction between Hsp110 and STAT3, thereby ameliorating pulmonary vascular remodeling in hypoxia-induced PAH rat models.